Approval Year
| Substance Class |
Protein
Created
by
admin
on
Edited
Mon Mar 31 21:27:04 GMT 2025
by
admin
on
Mon Mar 31 21:27:04 GMT 2025
|
| Protein Type | VACCINE ANTIGEN |
| Protein Sub Type | T-CELL ANTIGEN |
| Sequence Origin | VIRAL |
| Sequence Type | COMPLETE |
| Record UNII |
HM7AT2E2B6
|
| Record Status |
Validated (UNII)
|
| Record Version |
|
-
Download
| Name | Type | Language | ||
|---|---|---|---|---|
|
Preferred Name | English | ||
|
Code | English | ||
|
Systematic Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Code | English |
| Classification Tree | Code System | Code | ||
|---|---|---|---|---|
|
FDA ORPHAN DRUG |
74893
Created by
admin on Mon Mar 31 21:27:04 GMT 2025 , Edited by admin on Mon Mar 31 21:27:04 GMT 2025
|
| Code System | Code | Type | Description | ||
|---|---|---|---|---|---|
|
186511-30-8
Created by
admin on Mon Mar 31 21:27:04 GMT 2025 , Edited by admin on Mon Mar 31 21:27:04 GMT 2025
|
PRIMARY | |||
|
HM7AT2E2B6
Created by
admin on Mon Mar 31 21:27:04 GMT 2025 , Edited by admin on Mon Mar 31 21:27:04 GMT 2025
|
PRIMARY |
| Related Record | Type | Details | ||
|---|---|---|---|---|
|
|
TARGET ORGANISM->VACCINE ANTIGEN |
T-cell antigen
|
||
|
|
TARGET->ANTIGEN |
T-cell antigen
|
| Related Record | Type | Details | ||
|---|---|---|---|---|
|
|
ACTIVE MOIETY |
|
Structural Modifications
| Modification Type | Location Site | Location Type | Residue Modified | Extent | Fragment Name | Fragment Approval |
|---|---|---|---|---|---|---|
| SUBSTITUTION | [1_1] | K | N,N'-DIPALMITOYL-LYSINE, L- | U8O6OM81KZ |
| Name | Property Type | Amount | Referenced Substance | Defining | Parameters | References |
|---|---|---|---|---|---|---|
| Molecular Formula | CHEMICAL |
|
||||
| MOL_WEIGHT:NUMBER(CALCULATED) | CHEMICAL |
|